Response functions as quantifiers of non-Markovianity

Quantum non-Markovianity is crucially related to the study of dynamical maps, which are usually derived for initially factorized system-bath states. We here demonstrate that linear response theory also provides a way to derive dynamical maps, but for initially correlated (and in general entangled) states. Importantly, these maps are always time-translational invariant and allow for a much simpler quantification of non-Markovianity compared to previous approaches. We apply our theory to the Caldeira-Leggett model, for which our quantifier is valid beyond linear response and can be expressed analytically. We find that a classical Brownian particle coupled to an Ohmic bath can already exhibit non-Markovian behaviour, a phenomenon related to the initial state preparation procedure. Furthermore, for a peaked spectral density we demonstrate that there is no monotonic relation between our quantifier and the system-bath coupling strength, the sharpness of the peak or the resonance frequency in the bath.Comment: Updated version with additional information. 5 + 5 pages incl. 2 figures. Comments are welcom

EU Wide Monitoring Survey of Polar Persistent Pollutants in European River Waters

This study provides the first EU-wide reconnaissance of the occurrence of polar organic persistent pollutants in European river waters. 122 individual water samples from over 100 European rivers, streams or similar water bodies from 27 European Countries were analysed for 35 selected compounds, comprising pharmaceuticals (e.g. carbamazepine, diclofenac), antibiotics (sulfamethoxazole), pesticides (e.g. 2,4-D, mecoprop, bentazone, terbutylazine), perfluorinated compounds PFCs (PFOS, PFOA), benzotriazoles (corrosion inhibitors), hormones (estrone, estradiol), and alkylphenolics (bisphenol A, nonylphenol). Only the dissolved (liquid) water phase, and not the suspend material was investigated. Around 40 laboratories actively participated in this sampling and monitoring exercise organised by the Joint Research Centre¿s Institute for Environment and Sustainability (JRC-IES) of the European Commission (EC) in autumn 2007. The selection of sampling sites was done by the participating EU Member States. The most frequently and at the highest concentration levels detected compounds were benzotriazole, caffeine, carbamazepine, tolyltriazole, and nonylphenoxy acetic acid (NPE1C). Other important substances identified were naproxen, bezafibrate, ibuprofen, gemfibrozil, PFOS, PFOA, sulfamethoxazole, isoproturon, diuron, and nonylphenol. The highest median concentrations of all samples were measured for benzotriazole (226 ng/L), caffeine (72 ng/L), carbamazepine (75 ng/L), tolyltriazole (140 ng/L), and NPE1C (233 ng/L). Relatively high perfluorooctanoate (PFOA) levels were detected in the Rivers Danube, Scheldt, Rhone, and Wyre, and ¿elevated¿ perfluorooctansulfonate (PFOS) concentrations in the Rivers Scheldt, Seine, Krka, Severn, Rhine, and Llobregat. A higher median concentration for all river samples was found for PFOS (6 ng/L), compared to PFOA (3 ng/L). Only about 10 % of the river water samples analysed could be classified as ¿very clean¿ in terms of chemical pollution, since they contained only a few compounds in very low concentrations. The most pristine water samples came from Estonia, Lithuania, and Sweden. For the target compounds chosen, we are proposing limit values in surface waters which are not based on eco-toxicological considerations; these warning levels are (for most compounds) close to the 90th percentile of all water samples analysed. A first EU-wide data set has been created on the occurrence of polar persistent pollutants in river surface waters to be used for continental scale risk assessment and related decision support.JRC.H.5-Rural, water and ecosystem resource

Validation of analytical methods for the WFD “watch list” pilot exercise

Validation of an analytical method is a necessary step in controlling the quality of quantitative analysis. Method validation is an established process which is the provision of documentary evidence that a system fulfills its pre-defined specification or the process of providing that an analytical method is acceptable for its intended purpose. The objectives of the present study were: • to validate a SPE-LC-MS/MS method for the determination of carbamazepine (CBZ), 10,11-dihydro-10,11-dihydroxy-carbamazepine (CBZ-DiOH), sulfamethoxazole (SMZ) and pentafluoropropionic acid (PFPrA) in surface water samples; • to validate a SPE-GC-MS method for the determination of tris (1-chloro-2-propyl) phosphate (TCPP) content in surface water samples. Method validations were performed according to the ISO 17025 requirement and the BT/TF151 WI CSS 99026 document. The calibration curves, working ranges, recoveries, detection and quantification limits, trueness as well as repeatability were determined. The budget uncertainty was also estimated following a top-down approach based on in-house validation data.JRC.H.1-Water Resource

Clinical decision making and mental health service use in people with severe mental illness across Europe

Objective: This study aims to explore relationships between preferred and experienced clinical decision making with service use, and associated costs, by people with severe mental illness. Methods: Prospective observational study of mental healthcare in six European countries: Germany, UK, Italy Hungary, Denmark and Switzerland. Patients (N = 588) and treating clinicians (N = 213) reported preferred and experienced decision making at baseline using the Clinical Decision Making Style Scale (CDMS) and the Clinical Decision Involvement and Satisfaction Scale (CDIS). Retrospective service use was assessed with the Client Socio-Demographic and Service Receipt Inventory (CSSRI-EU) at baseline and 12-month follow-up. Negative binomial regression analyses examined the effects of CDMS and CDIS on service use and inpatient costs at baseline and multilevel models examined these relationships over time. Results: At baseline, staff and patient preferences for active decision making and low patient satisfaction with experienced decisions were associated with longer hospital admissions and higher costs. Patient preferences for active decision making predicted increases in hospital admissions (b = .236, p =.043) over 12 months and cost increases were predicted by low patient satisfaction (b = 4803, p =.005). Decision making was unrelated to medication, outpatient, or community service use. Conclusions: Decision making is related to inpatient service use and associated costs by people with severe mental illness. A preference for shared decision making may reduce healthcare costs via a reduction in inpatient admissions. Patient satisfaction with decisions is a crucial predictor of healthcare costs; therefore, clinicians should maximize patient satisfaction with decision making

Gemeinsame Entscheidungsfindung in der Behandlung von Patienten mit schweren psychischen Erkrankungen:Eine Fokusgruppenuntersuchung

Objective: Shared decision-making during the course of treatment is important for people with severe mental illness. However, there is still insufficient knowledge about how people with mental illness view decisions, what kind of decisions are made and how patients experience and perceive the process of participation in routine care. Methods: A qualitative study with focus groups was conducted with patients with chronic mental illness currently receiving outpatient care (N=23). Interviews were audio-taped, transcribed, coded and content analysed. Results: Three main themes were extracted from the data: 1. perception of the clinician and participation, 2. process of communication and flow of information, 3. decisions and transfer. Conclusions: The perception of participation in the decision process depends on a good patient-doctor relationship. Decisions made in the course of an outpatient long-term treatment are complex and are often not made during one single appointment. Frequently, patients seek the advice of people from their social network and/or other health professionals.</p

EU Wide Monitoring Survey on Waste Water Treatment Plant Effluents

In the year 2010, effluents from 90 European waste water treatment plants (WWTPs) were collected and analysed in total for 160 organic chemicals and 20 inorganic trace elements. The analyses were complemented by applying also effect-based monitoring approaches aiming at estrogenicity and dioxin-like toxicity analysed by in vitro reporter gene bioassays, and yeast and diatom culture acute toxicity optical bioassays. The analytical work was performed in six European expert laboratories. This European-wide monitoring study on the occurrence of micropollutants in WWTP effluents represents the largest EU wide monitoring survey on WWTP effluents ever performed. It produced a comprehensive data set on many so far only locally investigated “emerging” compound classes including pharmaceuticals and personal care products (PPCPs), veterinary (antibiotic) drugs, perfluoroalkyl substances (PFASs), organophosphate ester flame retardants, pesticides (and some metabolites) or industrial chemicals such as benzotriazoles (corrosion inhibitors), polycyclic musk fragrances, x-ray contrast agents, Gadolinium compounds, and siloxanes. The obtained results show the presence of 131 target organic compounds in European wastewater effluents, in concentrations ranging from low nanograms to milligrams per liter. These results obtained from 90 different European WWTPs allow the calculation of a European median level for the chemicals investigated. The most relevant compounds identified in the effluent water samples in terms of frecquency of detection, maximum, average and median concentration levels were Sucralose, Acesulfame K (artificial sweeteners), PFOA, PFHxA, PFHpA, PFOS (perfluoroalkyl substances), N,N’-Diethyltoluamide (DEET; insect repellent), Benzotriazoles (corrosion inhibitors), the pharmaceuticals Bisoprolol, Carbamazepine, Ciprofloxacine, Citaprolam, Clindamycine, Codeine, Diltiazem, Diphenhydramin, Eprosartan, Fexofenadine, Flecainide, Gemfibrozil, Fluconazole, Haloperidol, Ibersartan, Ibuprofen, Ketoprofen, Oxazepam, Risperidone, Sulfamethoxazole, Telmisartan, Tramadol, Trimethoprim, Venlafaxin, the organo-phosphate ester flame retardants Tri-iso-butylphosphate (TIBP), Tributylphosphate (TBP), Tris(2-chloroethyl)phosphate (TCEP), Tris(2-chloroisopropyl)phosphate (TCPP), Tris(2-butoxyethyl)phosphate (TDCP), Tris(2-butoxyethyl)phosphate (TBEP), Triphenyl-phosphate (TPP), 2-Ethylhexyldiphenyl-phosphate (EHDPP), the x-ray contrast media Amidotrizoic acid, Iohexol, Iopromid, Iomeprol, Iopamidol, the pesticides Terbutylazine, Terbutylazine-desethyl (metabolite), MCPA, Mecoprop, Diuron, Triclosan (antibacterial), and Gadolinium (from magnetic resonance imaging contrast media used in hospitals).JRC.H.1-Water Resource

Occurrence and levels of selected compounds in European compost and digestate samples

This report describes work conducted by the European Commission’s Joint Research Centre (JRC) in the context of an Administrative Arrangement between DG Environment and the JRC. This work aimed at the generation, within a limited timeframe, of a large amount of analytical data, with high scientific and statistical value, for a number of compost and digestate types (afterwards referred to as COMDIG samples), to help provide a general overview and estimation of that possible variability within and between different COMDIG materials. The report includes the results of a targeted and independent screening of typical European situations of COMDIG materials with regard to the occurrence and levels of compounds of concern, many of which have never been assessed at a pan-European level. In total, 139 samples, mostly taken as grab samples and originating from 15 countries, were assessed for 22 minor and trace elements and 92 organic compounds including ingredients of personal care products and pharmaceuticals. The underlying analytical methods are carefully documented with regard to their performance characteristics. Where available, the so-called “horizontal” standards were followed. The results obtained are assessed statistically. Although the analysed single samples are insufficient to make any statement on the performance of the treatment processes leading to COMDIG samples, this collective of data provide a glimpse of the pan-European situation as regards the studied compounds.JRC.H.1-Water Resource

Helping alliance and unmet needs in routine care of people with severe mental illness across Europe: a prospective longitudinal multicenter study

The helping alliance (HA) refers to the collaborative bond between patient and therapist including shared goals and tasks. People with severe mental illness have a complex mixture of clinical and social needs. Using mixed-effects regression, this study examined in 588 people with severe mental illness whether an increase in the HA is associated with fewer unmet needs over time, and whether change in the HA precedes change in unmet needs. It was found that a reduction of unmet needs was slower in patients with higher HA (B=0.04, p<.0001) only for patient-rated measures. Improvement in both patient-rated and staff-rated HA over time was associated with fewer subsequent patient- (B=-0.10, p<0.0001) and staff-rated (B=-0.08, p=0.0175) unmet needs. With positive changes in the HA preceding fewer unmet needs, findings provide further evidence for a causal relationship between alliance and outcome in the treatment of people with severe mental illness

Feasibility of a Monitoring Mechanism Supporting a Watch List under the Water Framework Directive

This report describes work conducted by the European Commission’s Joint Research Centre in the context of its support to the implementation of the Water Framework Directive 2000/60/EC. The work aimed at the feasibility assessment of an experimental monitoring exercise in support to a so-called Watch List Mechanism in a collaborative design involving EU Member States laboratories and some 200 official monitoring station operated by the Member States. The report includes all details on sampling stations, performance of analytical methods as well as the results of the analyses of all samples with regard to the occurrence and levels of 20 compounds of concern. In total, 219 whole water samples originating from 25 EU Member States and 2 other European countries, were assessed for contents of acesulfame, glyphosate and its metabolite AMPA, 1H-Benzotriazole and tolyltriazoles, bisphenol A, triclosan and triclocarban, carbamazepine and its metabolite 10,11-dihydro-10,11-dihydroxycarbamazepine, sulfamethoxazole, perfluoropropionic acid, tris-2-chloropropyl phosphate, methyl tert-butyl ether, silver, boron and chloride (Cl-) in water. Furthermore, 23 sediment samples were analysed for decabromodiphenylethane and decabromodiphenyl ether. The underlying analytical methods are carefully documented with regards to their performance characteristics. Obtained results are assessed statistically and where possible compared to other findings. Although the analysed single samples are insufficient to make any statement on the performance of the treatment processes leading to the compost, the collective of data allows having a glance at the pan-European situation as regards the studies compounds. Background information from literature describing the situation before the survey is included, too. The report is divided into a core part and two annexes. For practical reasons, the report is split into two volumes: Volume 1 contains the report and the single analytical results; volume 2 contains the documentation of the sampling stations.JRC.H.1-Water Resource